{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37972114", "DateCompleted": {"Year": "2023", "Month": "11", "Day": "20"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "20"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "11", "Day": "16"}], "Language": ["eng"], "ELocationID": ["e0294612", "10.1371/journal.pone.0294612"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "18", "Issue": "11", "PubDate": {"Year": "2023"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Anethole attenuates motor dysfunctions, striatal neuronal activity deficiency and blood brain barrier permeability by decreasing striatal \u03b1-synuclein and oxidative stress in rotenone-induced Parkinson's disease of male rats.", "Pagination": {"StartPage": "e0294612", "MedlinePgn": "e0294612"}, "Abstract": {"AbstractText": ["Anethole is the main compound of the essential oil of anise and several other plants, which has antioxidant, anti-inflammatory, and neuroprotective properties. Oxidative stress is considered as an important factor in the pathogenesis of PD. In the present study, we aimed to investigate the effects of anethole against rotenone-induced PD.", "Male Wistar rats were randomly divided into six groups. Control group received DMSO + sunflower oil, model group received rotenone (2 mg/kg, s.c, daily for 35 days), positive control group received L-Dopa, and test groups received anethole (62.5, 125, and 250\u2009mg/kg, i.g, daily for 35 days) 1 hour before each rotenone injection. Body weight changes, rotarod test, stride length test, and extracellular single unit recording were performed after treatment. After behavioral test, Brain water content and blood brain barrier (BBB) permeability were evaluated, and the levels of malondialdehyde (MDA), superoxide dismutases (SOD), alpha-synuclein and MAO-B were measured in the striatum.", "Chronic administration of rotenone induced body weight loss and caused significant dysfunction in locomotor activity, neuronl firing rate, and BBB. Rotenone also decreased SOD activity, increased MDA level, and elevated the expression of alpha-synuclein and MAO-B in the striatum. However, treatment with anethole attenuated body weight loss, motor function, neuronal activity, and BBB function. Furthermore, Anethole treatment attenuated oxidative stress and decreased the expression of alpha-synuclein and MAO-B compared to the rotenone group.", "Our results show that through its antioxidant properties, aethole can improve the cellular, molecular and behavioral characteristics of rotenone-induced Parkinson's disease."], "CopyrightInformation": "Copyright: \u00a9 2023 Moradi Vastegani et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}, {"Identifier": [], "Affiliation": "Department of Physiology, Medicine Faculty, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}], "LastName": "Moradi Vastegani", "ForeName": "Sadegh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}], "LastName": "Khoshnam", "ForeName": "Seyed Esmaeil", "Initials": "SE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}, {"Identifier": [], "Affiliation": "Department of Physiology, Medicine Faculty, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}], "LastName": "Ghafouri", "ForeName": "Samireh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pain Research Center, Imam Khomeini Hospital, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}], "LastName": "Bakhtiari", "ForeName": "Nima", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}, {"Identifier": [], "Affiliation": "Department of Physiology, Medicine Faculty, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}], "LastName": "Farbood", "ForeName": "Yaghoob", "Initials": "Y"}, {"Identifier": ["0000-0002-2874-1738"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Persian Gulf Physiology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}, {"Identifier": [], "Affiliation": "Department of Physiology, Medicine Faculty, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}, {"Identifier": [], "Affiliation": "Medicinal Plant Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran."}], "LastName": "Sarkaki", "ForeName": "Alireza", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "03L9OT429T", "NameOfSubstance": "Rotenone"}, {"RegistryNumber": "0", "NameOfSubstance": "alpha-Synuclein"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "Q3JEK5DO4K", "NameOfSubstance": "anethole"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "EC 1.15.1.1", "NameOfSubstance": "Superoxide Dismutase"}, {"RegistryNumber": "EC 1.4.3.4", "NameOfSubstance": "Monoamine Oxidase"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy", "etiology", "metabolism"], "DescriptorName": "Parkinson Disease"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Rotenone"}, {"QualifierName": ["metabolism"], "DescriptorName": "alpha-Synuclein"}, {"QualifierName": ["pharmacology", "metabolism"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["metabolism"], "DescriptorName": "Blood-Brain Barrier"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": [], "DescriptorName": "Oxidative Stress"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Superoxide Dismutase"}, {"QualifierName": ["metabolism"], "DescriptorName": "Monoamine Oxidase"}, {"QualifierName": [], "DescriptorName": "Weight Loss"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}], "CoiStatement": "The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Reyes JF, Ekmark-L\u00e9wen S, Perdiki M, Klingstedt T, Hoffmann A, Wiechec E, et al.. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson\u2019s disease. Acta Neuropathologica Communications. 2021;9(1):46. doi: 10.1186/s40478-021-01136-3", "ArticleIdList": ["10.1186/s40478-021-01136-3", "PMC7980682", "33743820"]}, {"Citation": "V\u00e1radi C. Clinical Features of Parkinson\u2019s Disease: The Evolution of Critical Symptoms. Biology (Basel). 2020;9(5):103. doi: 10.3390/biology9050103", "ArticleIdList": ["10.3390/biology9050103", "PMC7285080", "32438686"]}, {"Citation": "Pont-Sunyer C, Hotter A, Gaig C, Seppi K, Compta Y, Katzenschlager R, et al.. The onset of nonmotor symptoms in Parkinson\u2019s disease (the ONSET PD study). Mov Disord. 2015;30(2):229\u201337. doi: 10.1002/mds.26077", "ArticleIdList": ["10.1002/mds.26077", "25449044"]}, {"Citation": "Casanova Y, Negro S, Barcia E. Application of neurotoxin-and pesticide-induced animal models of Parkinson\u2019s disease in the evaluation of new drug delivery systems. Acta Pharmaceutica. 2022;72(1):35\u201358. doi: 10.2478/acph-2022-0008", "ArticleIdList": ["10.2478/acph-2022-0008", "36651528"]}, {"Citation": "Konnova EA, Swanberg M. Animal models of Parkinson\u2019s disease. Exon Publications. 2018:83\u2013106.", "ArticleIdList": ["30702844"]}, {"Citation": "Miyazaki I, Isooka N, Imafuku F, Sun J, Kikuoka R, Furukawa C, et al.. Chronic systemic exposure to low-dose rotenone induced central and peripheral neuropathology and motor deficits in mice: reproducible animal model of Parkinson\u2019s disease. International journal of molecular sciences. 2020;21(9):3254. doi: 10.3390/ijms21093254", "ArticleIdList": ["10.3390/ijms21093254", "PMC7246801", "32375371"]}, {"Citation": "Morais LH, Hara DB, Bicca MA, Poli A, Takahashi RN. Early signs of colonic inflammation, intestinal dysfunction, and olfactory impairments in the rotenone-induced mouse model of Parkinson\u2019s disease. Behavioural pharmacology. 2018;29(2):199\u2013210. doi: 10.1097/FBP.0000000000000389", "ArticleIdList": ["10.1097/FBP.0000000000000389", "29543651"]}, {"Citation": "Zhang Y, Guo H, Guo X, Ge D, Shi Y, Lu X, et al.. Involvement of Akt/mTOR in the Neurotoxicity of Rotenone-Induced Parkinson\u2019s Disease Models. International journal of environmental research and public health. 2019;16(20):3811. doi: 10.3390/ijerph16203811", "ArticleIdList": ["10.3390/ijerph16203811", "PMC6843606", "31658620"]}, {"Citation": "Miyazaki I, Isooka N, Imafuku F, Sun J, Kikuoka R, Furukawa C, et al.. Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson\u2019s Disease. International journal of molecular sciences. 2020;21(9):3254. doi: 10.3390/ijms21093254", "ArticleIdList": ["10.3390/ijms21093254", "PMC7246801", "32375371"]}, {"Citation": "Ruan Z, Zhang D, Huang R, Sun W, Hou L, Zhao J, et al.. Microglial Activation Damages Dopaminergic Neurons through MMP-2/-9-Mediated Increase of Blood-Brain Barrier Permeability in a Parkinson\u2019s Disease Mouse Model. International journal of molecular sciences. 2022;23(5):2793. doi: 10.3390/ijms23052793", "ArticleIdList": ["10.3390/ijms23052793", "PMC8910886", "35269933"]}, {"Citation": "Ramalingam M, Huh YJ, Lee YI. The Impairments of \u03b1-Synuclein and Mechanistic Target of Rapamycin in Rotenone-Induced SH-SY5Y Cells and Mice Model of Parkinson\u2019s Disease. Front Neurosci. 2019;13:1028.", "ArticleIdList": ["PMC6769080", "31611767"]}, {"Citation": "Domiciano TP, de Oliveira Dalalio MM, Silva EL, Ritter AMV, Estev\u00e3o-Silva CF, Ramos FS, et al.. Inhibitory effect of anethole in nonimmune acute inflammation. Naunyn-Schmiedeberg\u2019s archives of pharmacology. 2013;386(4):331\u20138. doi: 10.1007/s00210-012-0820-5", "ArticleIdList": ["10.1007/s00210-012-0820-5", "23250338"]}, {"Citation": "Freire RS, Morais SM, Catunda-Junior FEA, Pinheiro DC. Synthesis and antioxidant, anti-inflammatory and gastroprotector activities of anethole and related compounds. Bioorganic & medicinal chemistry. 2005;13(13):4353\u20138. doi: 10.1016/j.bmc.2005.03.058", "ArticleIdList": ["10.1016/j.bmc.2005.03.058", "15890516"]}, {"Citation": "Anjos J, Aguiar F, S\u00e1 N, Souza J, Cibin F, Alves B, et al.. Anethole improves blastocysts rates together with antioxidant capacity when added during bovine embryo culture rather than in the in vitro maturation medium. Zygote. 2019;27(6):382\u20135. doi: 10.1017/S0967199419000443", "ArticleIdList": ["10.1017/S0967199419000443", "31451120"]}, {"Citation": "Kosalec I, Pepeljnjak S, KU\u0160TRAK D. Antifungal activity of fluid extract and essential oil from anise fruits (Pimpinella anisum L., Apiaceae). Acta Pharmaceutica. 2005;55(4):377\u201385.", "ArticleIdList": ["16375827"]}, {"Citation": "Yang J-F, Yang C-H, Chang H-W, Yang C-S, Wang S-M, Hsieh M-C, et al.. Chemical composition and antibacterial activities of Illicium verum against antibiotic-resistant pathogens. Journal of medicinal food. 2010;13(5):1254\u201362. doi: 10.1089/jmf.2010.1086", "ArticleIdList": ["10.1089/jmf.2010.1086", "20828316"]}, {"Citation": "Ritter AM, Domiciano TP, Verri WA, Zarpelon AC, da Silva LG, Barbosa CP, et al.. Antihypernociceptive activity of anethole in experimental inflammatory pain. Inflammopharmacology. 2013;21(2):187\u201397. doi: 10.1007/s10787-012-0152-6", "ArticleIdList": ["10.1007/s10787-012-0152-6", "23054333"]}, {"Citation": "Ghelardini C, Galeotti N, Mazzanti G. Local anaesthetic activity of monoterpenes and phenylpropanes of essential oils. Planta medica. 2001;67(06):564\u20136. doi: 10.1055/s-2001-16475", "ArticleIdList": ["10.1055/s-2001-16475", "11509984"]}, {"Citation": "Drukarch B, Schepens E, Stoof JC, Langeveld CH. Anethole dithiolethione prevents oxidative damage in glutathione-depleted astrocytes. European journal of pharmacology. 1997;329(2\u20133):259\u201362.", "ArticleIdList": ["9226421"]}, {"Citation": "Ryu S, Seol GH, Park H, Choi I-Y. Trans-anethole protects cortical neuronal cells against oxygen\u2013glucose deprivation/reoxygenation. Neurological Sciences. 2014;35(10):1541\u20137. doi: 10.1007/s10072-014-1791-8", "ArticleIdList": ["10.1007/s10072-014-1791-8", "24777545"]}, {"Citation": "Bhadra S, Mukherjee PK, Kumar NS, Bandyopadhyay A. Anticholinesterase activity of standardized extract of Illicium verum Hook. f. fruits. Fitoterapia. 2011;82(3):342\u20136.", "ArticleIdList": ["21075180"]}, {"Citation": "Vastegani SM, Khoshnam SE, Mansouri E, Hajipour S, Ghafouri S, Bakhtiari N, et al.. Neuroprotective effect of anethole against rotenone induced non-motor deficits and oxidative stress in rat model of Parkinson\u2019s disease. Behav Brain Res. 2023;437:114100. doi: 10.1016/j.bbr.2022.114100", "ArticleIdList": ["10.1016/j.bbr.2022.114100", "36075399"]}, {"Citation": "Moradi Vastegani S, Khoshnam SE, Mansouri E, Ghafouri S, Bakhtiari N, Farbood Y, et al.. Anti-inflammatory, anti-apoptotic, and neuroprotective potentials of anethole in Parkinson\u2019s disease-like motor and non-motor symptoms induced by rotenone in rats. Metab Brain Dis. 2023:1\u201316.", "ArticleIdList": ["37204660"]}, {"Citation": "Drukarch B, Flier J, Jongenelen C, Andringa G, Schoffelmeer A. The antioxidant anethole dithiolethione inhibits monoamine oxidase-B but not monoamine oxidase A activity in extracts of cultured astrocytes. Journal of neural transmission (Vienna). 2006;113(5):593\u20138. doi: 10.1007/s00702-005-0350-0", "ArticleIdList": ["10.1007/s00702-005-0350-0", "16252076"]}, {"Citation": "Aprotosoaie AC, Costache I-I, Miron A. Anethole and its role in chronic diseases. Drug Discovery from Mother Nature. 2016:247\u201367. doi: 10.1007/978-3-319-41342-6_11", "ArticleIdList": ["10.1007/978-3-319-41342-6_11", "27771928"]}, {"Citation": "Sharma S, Kumar P, Deshmukh R. Neuroprotective potential of spermidine against rotenone induced Parkinson\u2019s disease in rats. Neurochemistry International. 2018;116:104\u201311. doi: 10.1016/j.neuint.2018.02.010", "ArticleIdList": ["10.1016/j.neuint.2018.02.010", "29501454"]}, {"Citation": "Jakkamsetti V, Scudder W, Kathote G, Ma Q, Angulo G, Dobariya A, et al.. Quantification of early learning and movement sub-structure predictive of motor performance. Scientific reports. 2021;11(1):1\u201314.", "ArticleIdList": ["PMC8277799", "34257385"]}, {"Citation": "Jalali MS, Sarkaki A, Farbood Y, Azandeh SS, Mansouri E, Dehcheshmeh MG, et al.. Neuroprotective effects of Wharton\u2019s jelly-derived mesenchymal stem cells on motor deficits due to Parkinson\u2019s disease. Iranian Journal of Basic Medical Sciences. 2021;24(9):1173. doi: 10.22038/IJBMS.2021.54091.12159", "ArticleIdList": ["10.22038/IJBMS.2021.54091.12159", "PMC8751748", "35083003"]}, {"Citation": "Hajipour S, Sarkaki A, Dianat M, Rashno M, Khorsandi LS, Farbood Y. The effects of thymoquinone on memory impairment and inflammation in rats with hepatic encephalopathy induced by thioacetamide. Metab Brain Dis. 2021;36(5):991\u20131002. doi: 10.1007/s11011-021-00688-6", "ArticleIdList": ["10.1007/s11011-021-00688-6", "33620578"]}, {"Citation": "Hajipour S, Farbood Y, Gharib-Naseri MK, Goudarzi G, Rashno M, Maleki H, et al.. Exposure to ambient dusty particulate matter impairs spatial memory and hippocampal LTP by increasing brain inflammation and oxidative stress in rats. Life Sciences. 2020;242:117210. doi: 10.1016/j.lfs.2019.117210", "ArticleIdList": ["10.1016/j.lfs.2019.117210", "31874166"]}, {"Citation": "Vestegani SM, Hajipour S, Sarkaki A, Basir Z, Navabi SP, Khoshnam SE. Curcumin mitigates lipopolysaccharide-induced anxiety/depression-like behaviors, blood-brain barrier dysfunction and brain edema by decreasing cerebral oxidative stress in male rats. Neuroscience Letters. 2022:136697. doi: 10.1016/j.neulet.2022.136697", "ArticleIdList": ["10.1016/j.neulet.2022.136697", "35642797"]}, {"Citation": "Tseng H-C, Wang M-H, Chang K-C, Soung H-S, Fang C-H, Lin Y-W, et al.. Protective effect of (\u2212) epigallocatechin-3-gallate on rotenone-induced parkinsonism-like symptoms in rats. Neurotoxicity Research. 2020;37(3):669\u201382. doi: 10.1007/s12640-019-00143-6", "ArticleIdList": ["10.1007/s12640-019-00143-6", "31811588"]}, {"Citation": "Kei S. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clinica chimica acta. 1978;90(1):37\u201343.", "ArticleIdList": ["719890"]}, {"Citation": "Kono Y. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Archives of biochemistry and biophysics. 1978;186(1):189\u201395. doi: 10.1016/0003-9861(78)90479-4", "ArticleIdList": ["10.1016/0003-9861(78)90479-4", "24422"]}, {"Citation": "Jakova E, Moutaoufik MT, Lee JS, Babu M, Cayabyab FS. Adenosine A1 receptor ligands bind to \u03b1-synuclein: implications for \u03b1-synuclein misfolding and \u03b1-synucleinopathy in Parkinson\u2019s disease. Translational Neurodegeneration. 2022;11(1):9.", "ArticleIdList": ["PMC8830172", "35139916"]}, {"Citation": "Elfawy HA, Das B. Crosstalk between mitochondrial dysfunction, oxidative stress, and age related neurodegenerative disease: Etiologies and therapeutic strategies. Life sciences. 2019;218:165\u201384. doi: 10.1016/j.lfs.2018.12.029", "ArticleIdList": ["10.1016/j.lfs.2018.12.029", "30578866"]}, {"Citation": "Gaki GS, Papavassiliou AG. Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson\u2019s disease. Neuromolecular medicine. 2014;16(2):217\u201330. doi: 10.1007/s12017-014-8294-x", "ArticleIdList": ["10.1007/s12017-014-8294-x", "24522549"]}, {"Citation": "Speer H D \u2019Cunha NM, Alexopoulos NI, McKune AJ, Naumovski N. Anthocyanins and human health\u2014a focus on oxidative stress, inflammation and disease. Antioxidants. 2020;9(5):366. doi: 10.3390/antiox9050366", "ArticleIdList": ["10.3390/antiox9050366", "PMC7278778", "32353990"]}, {"Citation": "Heinz S, Freyberger A, Lawrenz B, Schladt L, Schmuck G, Ellinger-Ziegelbauer H. Mechanistic investigations of the mitochondrial complex I inhibitor rotenone in the context of pharmacological and safety evaluation. Scientific reports. 2017;7(1):1\u201313.", "ArticleIdList": ["PMC5379642", "28374803"]}, {"Citation": "Terron A, Bal-Price A, Paini A, Monnet-Tschudi F, Bennekou SH, Leist M, et al.. An adverse outcome pathway for parkinsonian motor deficits associated with mitochondrial complex I inhibition. Archives of Toxicology. 2018;92(1):41\u201382. doi: 10.1007/s00204-017-2133-4", "ArticleIdList": ["10.1007/s00204-017-2133-4", "PMC5773657", "29209747"]}, {"Citation": "Zhang L, Hao J, Zheng Y, Su R, Liao Y, Gong X, et al.. Fucoidan protects dopaminergic neurons by enhancing the mitochondrial function in a rotenone-induced rat model of Parkinson\u2019s disease. Aging and disease. 2018;9(4):590. doi: 10.14336/AD.2017.0831", "ArticleIdList": ["10.14336/AD.2017.0831", "PMC6065300", "30090649"]}, {"Citation": "Johnson ME, Bobrovskaya L. An update on the rotenone models of Parkinson\u2019s disease: their ability to reproduce the features of clinical disease and model gene-environment interactions. Neurotoxicology. 2015;46:101\u201316. doi: 10.1016/j.neuro.2014.12.002", "ArticleIdList": ["10.1016/j.neuro.2014.12.002", "25514659"]}, {"Citation": "Xiong N, Long X, Xiong J, Jia M, Chen C, Huang J, et al.. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson\u2019s disease models. Crit Rev Toxicol. 2012;42(7):613\u201332. doi: 10.3109/10408444.2012.680431", "ArticleIdList": ["10.3109/10408444.2012.680431", "22574684"]}, {"Citation": "Ahmed MR, Shaikh MA, Baloch NA, Nazir S, Abrar H, Imran Ulhaq HS. Neuroprotective Potential of Polydatin Against Motor Abnormalities and Dopaminergic Neuronal Loss in Rotenone Induced Parkinson Model. International Journal of Morphology. 2018;36(2)."}, {"Citation": "Xiong ZK, Lang J, Xu G, Li HY, Zhang Y, Wang L, et al.. Excessive levels of nitric oxide in rat model of Parkinson\u2019s disease induced by rotenone. Experimental and Therapeutic Medicine. 2015;9(2):553\u20138. doi: 10.3892/etm.2014.2099", "ArticleIdList": ["10.3892/etm.2014.2099", "PMC4280943", "25574233"]}, {"Citation": "Ghasemi-Dehnoo M, Safari AA, Rahimi-Madiseh M, Lorigooini Z, Moradi MT, Amini-Khoei H. Anethole Ameliorates Acetic Acid-Induced Colitis in Mice: Anti-Inflammatory and Antioxidant Effects. Evid Based Complement Alternat Med. 2022;2022:9057451. doi: 10.1155/2022/9057451", "ArticleIdList": ["10.1155/2022/9057451", "PMC9007635", "35432569"]}, {"Citation": "Yu C, Wang T, Yang Z. Effects of dietary supplementation of trans-anethole on the intestinal antioxidant status, immune function, and liver lipid metabolism in broilers. Italian Journal of Animal Science. 2022;21(1):729\u201336."}, {"Citation": "Drukarch B, van Muiswinkel FL. Neuroprotection for Parkinson\u2019s disease: a new approach for a new millennium. Expert Opin Investig Drugs. 2001;10(10):1855\u201368. doi: 10.1517/13543784.10.10.1855", "ArticleIdList": ["10.1517/13543784.10.10.1855", "11772291"]}, {"Citation": "Raman S, Asle-Rousta M, Rahnema M. Protective effect of fennel, and its major component trans-anethole against social isolation induced behavioral deficits in rats. Physiol Int. 2020;107(1):30\u20139. doi: 10.1556/2060.2020.00012", "ArticleIdList": ["10.1556/2060.2020.00012", "32491286"]}, {"Citation": "Kuriakose M, Younger D, Ravula AR, Alay E, Rama Rao KV, Chandra N. Synergistic role of oxidative stress and blood-brain barrier permeability as injury mechanisms in the acute pathophysiology of blast-induced neurotrauma. Scientific reports. 2019;9(1):1\u201312.", "ArticleIdList": ["PMC6531444", "31118451"]}, {"Citation": "Khoshnam SE, Farbood Y, Fathi Moghaddam H, Sarkaki A, Badavi M, Khorsandi L. Vanillic acid attenuates cerebral hyperemia, blood-brain barrier disruption and anxiety-like behaviors in rats following transient bilateral common carotid occlusion and reperfusion. Metab Brain Dis. 2018;33(3):785\u201393. doi: 10.1007/s11011-018-0187-5", "ArticleIdList": ["10.1007/s11011-018-0187-5", "29356980"]}, {"Citation": "Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008;57(2):178\u2013201. doi: 10.1016/j.neuron.2008.01.003", "ArticleIdList": ["10.1016/j.neuron.2008.01.003", "18215617"]}, {"Citation": "Kim SY, Buckwalter M, Soreq H, Vezzani A, Kaufer D. Blood-brain barrier dysfunction-induced inflammatory signaling in brain pathology and epileptogenesis. Epilepsia. 2012;53 Suppl 6(0 6):37\u201344. doi: 10.1111/j.1528-1167.2012.03701.x", "ArticleIdList": ["10.1111/j.1528-1167.2012.03701.x", "PMC3703535", "23134494"]}, {"Citation": "Chung TD, Linville RM, Guo Z, Ye R, Jha R, Grifno GN, et al.. Effects of acute and chronic oxidative stress on the blood\u2013brain barrier in 2D and 3D in vitro models. Fluids and Barriers of the CNS. 2022;19(1):33. doi: 10.1186/s12987-022-00327-x", "ArticleIdList": ["10.1186/s12987-022-00327-x", "PMC9097350", "35551622"]}, {"Citation": "S\u00e1 NAR, Bruno JB, Guerreiro DD, Cadenas J, Alves BG, Cibin FWS, et al.. Anethole reduces oxidative stress and improves in vitro survival and activation of primordial follicles. Braz J Med Biol Res. 2018;51(8):e7129\u2013e. doi: 10.1590/1414-431x20187129", "ArticleIdList": ["10.1590/1414-431x20187129", "PMC5999067", "29846431"]}, {"Citation": "Kang P, Kim KY, Lee HS, Min SS, Seol GH. Anti-inflammatory effects of anethole in lipopolysaccharide-induced acute lung injury in mice. Life Sci. 2013;93(24):955\u201361.", "ArticleIdList": ["24404587"]}, {"Citation": "Pandit K, Kumar A, Kaur S, Kumar V, Jain SK, Bhardwaj R, et al.. Amelioration of oxidative stress by trans-Anethole via modulating phase I and phase II enzymes against hepatic damage induced by CCl4 in male Wistar rats. Environmental Science and Pollution Research. 2022;29(4):6317\u201333. doi: 10.1007/s11356-021-16070-z", "ArticleIdList": ["10.1007/s11356-021-16070-z", "34453252"]}, {"Citation": "Chen Y, Qin C, Huang J, Tang X, Liu C, Huang K, et al.. The role of astrocytes in oxidative stress of central nervous system: A mixed blessing. Cell Prolif. 2020;53(3):e12781\u2013e. doi: 10.1111/cpr.12781", "ArticleIdList": ["10.1111/cpr.12781", "PMC7106951", "32035016"]}, {"Citation": "Bastioli G, Piccirillo S, Castaldo P, Magi S, Tozzi A, Amoroso S, et al.. Selective inhibition of mitochondrial sodium-calcium exchanger protects striatal neurons from \u03b1-synuclein plus rotenone induced toxicity. Cell Death & Disease. 2019;10(2):80.", "ArticleIdList": ["PMC6349907", "30692508"]}, {"Citation": "Costa C, Belcastro V, Tozzi A, Di Filippo M, Tantucci M, Siliquini S, et al.. Electrophysiology and pharmacology of striatal neuronal dysfunction induced by mitochondrial complex I inhibition. J Neurosci. 2008;28(32):8040\u201352. doi: 10.1523/JNEUROSCI.1947-08.2008", "ArticleIdList": ["10.1523/JNEUROSCI.1947-08.2008", "PMC6670775", "18685029"]}, {"Citation": "Yuan Y-h Yan W-f, Sun J-d Huang J-y, Mu Z Chen N-H. The molecular mechanism of rotenone-induced \u03b1-synuclein aggregation: emphasizing the role of the calcium/GSK3\u03b2 pathway. Toxicology letters. 2015;233(2):163\u201371.", "ArticleIdList": ["25433145"]}, {"Citation": "Zakharov SD, Hulleman JD, Dutseva EA, Antonenko YN, Rochet J-C, Cramer WA. Helical \u03b1-synuclein forms highly conductive ion channels. Biochemistry. 2007;46(50):14369\u201379.", "ArticleIdList": ["18031063"]}, {"Citation": "Lai TT, Kim YJ, Ma H-i, Kim YE. Evidence of Inflammation in Parkinson\u2019s Disease and Its Contribution to Synucleinopathy. Journal of Movement Disorders. 2022;15(1):1. doi: 10.14802/jmd.21078", "ArticleIdList": ["10.14802/jmd.21078", "PMC8820875", "35124957"]}, {"Citation": "Blesa J, Phani S, Jackson-Lewis V, Przedborski S. Classic and new animal models of Parkinson\u2019s disease. J Biomed Biotechnol. 2012;2012:845618-. doi: 10.1155/2012/845618", "ArticleIdList": ["10.1155/2012/845618", "PMC3321500", "22536024"]}, {"Citation": "Maniyath SP, Solaiappan N, Rathinasamy M. Neurobehavioural Changes in a Hemiparkinsonian Rat Model Induced by Rotenone. J Clin Diagn Res. 2017;11(3):AF01\u2013AF5. doi: 10.7860/JCDR/2017/24955.9604", "ArticleIdList": ["10.7860/JCDR/2017/24955.9604", "PMC5427293", "28511367"]}, {"Citation": "Zhang ZN, Zhang JS, Xiang J, Yu ZH, Zhang W, Cai M, et al.. Subcutaneous rotenone rat model of Parkinson\u2019s disease: Dose exploration study. Brain Res. 2017;1655:104\u201313. doi: 10.1016/j.brainres.2016.11.020", "ArticleIdList": ["10.1016/j.brainres.2016.11.020", "27876560"]}, {"Citation": "Shimozawa A, Fujita Y, Kondo H, Takimoto Y, Terada M, Sanagi M, et al.. Effect of L-DOPA/Benserazide on Propagation of Pathological \u03b1-Synuclein. Frontiers in neuroscience. 2019;13:595\u2013.", "ArticleIdList": ["PMC6587610", "31258461"]}, {"Citation": "Schapira AHV. Chapter 18\u2014Neuroprotection in Parkinson\u2019s Disease. In: Schapira AHV, Lang AET, Fahn S, editors. Blue Books of Neurology. 34: Butterworth-Heinemann; 2010. p. 301\u201320."}, {"Citation": "Zheng C, Chen G, Tan Y, Zeng W, Peng Q, Wang J, et al.. TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone. Front Cell Neurosci. 2018;12:485\u2013. doi: 10.3389/fncel.2018.00485", "ArticleIdList": ["10.3389/fncel.2018.00485", "PMC6306470", "30618632"]}, {"Citation": "Ogunruku OO, Ogunyemi BO, Oboh G, Babatunde OO, Boligon AA. Modulation of dopamine metabolizing enzymes and antioxidant status by Capsicum annuum Lin in rotenone-intoxicated rat brain. Toxicology Reports. 2019;6:795\u2013802. doi: 10.1016/j.toxrep.2019.07.012", "ArticleIdList": ["10.1016/j.toxrep.2019.07.012", "PMC6700337", "31440456"]}, {"Citation": "Kang SS, Ahn EH, Zhang Z, Liu X, Manfredsson FP, Sandoval IM, et al.. \u03b1\u2010Synuclein stimulation of monoamine oxidase\u2010B and legumain protease mediates the pathology of Parkinson\u2019s disease. The EMBO journal. 2018;37(12):e98878.", "ArticleIdList": ["PMC6003650", "29769405"]}, {"Citation": "Mallajosyula JK, Kaur D, Chinta SJ, Rajagopalan S, Rane A, Nicholls DG, et al.. MAO-B elevation in mouse brain astrocytes results in Parkinson\u2019s pathology. PloS one. 2008;3(2):e1616\u2013e. doi: 10.1371/journal.pone.0001616", "ArticleIdList": ["10.1371/journal.pone.0001616", "PMC2229649", "18286173"]}, {"Citation": "Kang SS, Ahn EH, Zhang Z, Liu X, Manfredsson FP, Sandoval IM, et al.. \u03b1-Synuclein stimulation of monoamine oxidase-B and legumain protease mediates the pathology of Parkinson\u2019s disease. The EMBO journal. 2018;37(12):e98878.", "ArticleIdList": ["PMC6003650", "29769405"]}, {"Citation": "Rochet J-C, Liu F. Inhibition of \u03b1-synuclein aggregation by antioxidants and chaperones in Parkinson\u2019s disease. Protein folding and misfolding: neurodegenerative diseases: Springer; 2009. p. 175\u2013206."}, {"Citation": "Ilesanmi OB, Adewunmi R, Taiwo AT, Komolafe KC, Odewale TT, Akinmoladun AC, et al. Alteration of NADH Succinate Dehydrogenase Activity and Redox Status By Different Solvent Fractions of Antiaris Africana in the Brain of Rats Exposed To Rotenone. Biomedical Journal.1:7."}, {"Citation": "Niedzielska E, Smaga I, Gawlik M, Moniczewski A, Stankowicz P, Pera J, et al.. Oxidative stress in neurodegenerative diseases. Molecular neurobiology. 2016;53(6):4094\u2013125. doi: 10.1007/s12035-015-9337-5", "ArticleIdList": ["10.1007/s12035-015-9337-5", "PMC4937091", "26198567"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "6", "Day": "26"}, {"Year": "2023", "Month": "11", "Day": "3"}, {"Year": "2023", "Month": "11", "Day": "20", "Hour": "6", "Minute": "54"}, {"Year": "2023", "Month": "11", "Day": "17", "Hour": "15", "Minute": "31"}, {"Year": "2023", "Month": "11", "Day": "16", "Hour": "13", "Minute": "54"}, {"Year": "2023", "Month": "11", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["37972114", "PMC10653401", "10.1371/journal.pone.0294612", "PONE-D-23-18169"]}}], "PubmedBookArticle": []}